Back to Search
SAMUEL GUBA, MD
MD
Surgery Physician
NPI: 1326669409IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryGENERAL SURGERY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2020
Research & Publications (2)
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
PMID 19632943·Clin Lung Cancer·2009
3-trial
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.
PMID 17440727·Cancer Chemother Pharmacol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1102 Constitution Ave
Meridian, MS 39301 - Phone
- (601) 703-5000
Quick Facts
- NPI
- 1326669409
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 4
- Years in Practice
- 6
- Publications
- 2
Are you this provider?
Claim Your Profile